Protective effects of β-glucan extracted from barley against benzo[a]pyrene-induced DNA damage in hepatic cell HepG2

Experimental and Toxicologic Pathology

Volumn 61, Issue 1, 2009, Pages 83-89

  Angeli, José Pedro F ^a   Ribeiro, Lúcia R ^b   Angeli, José Lourenço F ^a   Mantovani, Mário S ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Glucan; Antigenotoxicity; Comet assay; HepG2

Indexed keywords

BENZO[A]PYRENE; BETA GLUCAN; DNA; FREE RADICAL; MUTAGENIC AGENT; PLANT EXTRACT;

ARTICLE; BARLEY; CELL METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; GEL ELECTROPHORESIS; GENOTOXICITY; HUMAN; HUMAN CELL; LIVER CELL; MODULATION; MUTAGENIC ACTIVITY; PROTECTION; CHEMISTRY; COMET ASSAY; DRUG EFFECTS; HORDEUM; PATHOLOGY; PHYTOTHERAPY; PROCEDURES; TOXICITY; TUMOR CELL LINE;

BENZO(A)PYRENE; BETA-GLUCANS; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; HEPATOCYTES; HORDEUM; HUMANS; MUTAGENS; PHYTOTHERAPY; PLANT EXTRACTS;

HORDEUM;

EID: 59249093615     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.05.003     Document Type: Article

References (33)

1. Angeli J.P.F., Ribeiro L.R., Gonzaga M.L.C., Soares de S.A., Ricardo M.P.S.N., Tsuboy M.S., et al. Protective effects of β-glucan extracted from Agaricus brasiliensis against chemically induced DNA damage in human lymphocytes. Cell Biol Toxicol 22 (2006) 285-291
2. Angeli J.P.F., Ribeiro L.R., Bellini M.F., and Mantovani M.S. Anti-clastogenic effect of beta-glucan extracted from barley towards chemically induced DNA damage in rodent cells. Hum Exp Toxicol 25 (2006) 319-324
3. Brown G.D., and Gordon S. Fungal β-glucans and mammalian immunity. Immunity 19 (2003) 311-315
4. Chen C., and Kong A.N.T. Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. TRENDS Pharmacol Sci 26 (2005) 318-326
5. Chorvatovicová D. Suppressing effects of glucan on micromuceli induced by Co60 in mice. Stranhlenther Onkol 167 (1991) 612-614
6. Cisneros R.L., Gibson F.C., and Tzianabos A.O. Passive transfer of poly-(1-6)-β-glucotriosyl-(1-3)-β-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis. Infect Immunol 64 (1996) 2201-2205
7. Devegowda G., Raju M.V.L.N., and Swamy H.V.L.N. Mycotoxins: novel solutions for their counteraction. Feedstuffs 70 (1998) 12-15
8. Falch B.H., Espevik T., Ryan L., and Stokke B.T. The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydr Res 329 (2000) 587-596
9. Ferguson L.R., and Harris P.J. The dietary fibre debate: more food for thought. Lancet 361 (2003) 1487-1488
10. Hofer M., and Pospisil M. Glucan as stimulator of hematopoiesis in normal and gamma-irradiated mice: a survey of the authors results. Int J Immunopharmaco 19 (1997) 607-609
11. Holbrook T.W., Cook J.A., and Parker B.W. Immunization against Leishmania dovavani: glucan as an adjuvant with killed promastigotes. Am J Trop Med Hyg 30 (1981) 762-768
12. Kada T., and Shimoi K. Desmutagens and bio-antimutagens - their mode of action. Bioessays 7 (1987) 113-116
13. Knasmüller S., Parzefall W., Sanyal R., Ecker S., Schwab C., Uhl M., et al. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res 402 (1998) 185-202
14. Kobayashi H., Sugiyama C., Morikawa Y., Hayashi M., and Sofuni T. A comparison between the manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis. MMS Commun 3 (1995) 103-115
15. Krizkova L., Zitnanova I., Mislovicova D., Masarova J., Sasinkova V., Durackova Z., et al. Antioxidant and antimutagenic activity of mannan neoglycoconjugates: Mannan-human serum albumin and mannan-penicillin G acylase. Mutat Res 606 (2006) 72-79
16. Lin H., She Y., Cassileth B., Sirotnak F., and Rundles S.C. Maitake Beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol 4 (2004) 91-99
17. Lindl T., and Bauer J. Zell- und gewebekultur (1994), Gustav Fischer Verlag, Stuttgart-Jena-New York
18. Meira D.A., Pereira P.C.M., Marcondes-Machado J., Barravieira R.P., Pellegrino J.R.J., Rezkallah-Iwasso M.T., et al. The use of glucan as immunostimulant in treatment of paracoccidiomycosis. Am J Trop Med Hyg 55 (1996) 496-503
19. Okamoto T., Kodoi R., and Nonaka Y. Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. Biofactors 21 (2004) 374-407
20. Oliveira R.J., Ribeiro L.R., Silva A.F., Matuo R., and Mantovani M.S. Evaluation of antimutagenic activity and mechanisms of action of β-glucan from barley, in CHO-k1 and HTC cell lines using the micronucleus test. Toxicol In Vitro 20 (2006) 1225-1233
21. Oliveira R.J., Matuo R., Silva A.F., Matiazi H.J., Mantovani M.S., and Ribeiro L.R. Protective effect of β-glucan extracted from Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (K1) and repair-deficient (xrs5) CHO cells. Toxicol In Vitro 21 (2007) 41-52
22. In: Potter J.P., Chavez A., and Chen J. (Eds). Food, nutrition and the prevention of cancer: a global perspective (1997), World Cancer Research Fund/American Institute for Cancer Research, Washington, DC
23. Rankin A.J., Sylvester I., Smith S., Yoshimura T., and Leonard E.J. Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J Clin Invest 86 (1990) 1556-1564
24. Reynolds J.A., Kastello M.D., Harrigton D.G., Crabs C.L., Peters C.J., Jemski J.V., et al. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect Immunol 30 (1980) 51-57
25. Slamenová D., Lábaj J., Krizková L., Kogan G., Sandula J., Bresgen N., et al. Protective effects of fungal β-D-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells. Cancer Lett 198 (2003) 153-160
26. Speit G., and Hartmann A. The comet assay: a sensitive genotoxicity test for the detection of DNA damage. Meth Mol Biol 291 (2005) 85-95
27. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35 (2000) 206-221
28. Tohamy A.A., El-Gohr A.A., El-Nahas S.M., and Noshy M.M. β-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin. Mutat Res 541 (2003) 45-53
29. Uhl M., Helma C., and Knasmüller S. Single cell gel electrophoresis assay with human-derived hepatoma (HepG2) cells. Mutat Res 441 (1999) 215-224
30. Uhl M., Helma C., and Knasmüller S. Evaluation of the single cell gel electrophoresis assay with human hepatoma (HepG2) cells. Mutat Res 468 (2000) 213-225
31. Weinstein I.B. Cancer prevention: recent progress and future opportunities. Cancer Res 51 (1991) 5080-5085
32. Zeiger E. Illusions of safety: antimutagens can be mutagens, and anticarcinogens can be carcinogens. Mutat Res 543 (2003) 191-194
33. Zekovic D.B., Kwiatkowski S., Vrvic M.M., Jakovljevic D., and Moran C.A. Natural and modified (1→3)-β-glucans in health promotion and disease alleviation. Crit Rev Biotechnol 25 (2005) 205-230